2m 2m 2m 2m 2m 2m 2m
CTT Pharma Holdi (CTTH)
OTC
$0.05-$0.003 (-5.82%)
Price as of Sep 10, 2026- N/AMarket Cap
- 13.30%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
CTT Pharma Holdi (CTTH)
$0.05-$0.003 (-5.82%)
CTTH | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.05 | ||
Change | -$0.003 (-5.82%) | ||
Open | $0.04 | ||
High | $0.06 | ||
Low | $0.04 | ||
Previous Close | $0.06 | ||
Volume | 143,458 | ||
30-Day Average Volume | 49,025 | ||
1-Week Change | 3.60% | ||
1-Month Change | -19.73% | ||
1-Year Change | 13.30% | ||
3-Year Change | 488.64% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 21.3M | ||
Total Assets | $922,038.00 | ||
Market Cap | N/A | ||
Enterprise Value | N/A | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$341,930.00 | ||
Free Cash Flow | -$15,527.00 | ||
EBIT | -$341,930.00 | ||
EBITDA | -$341,930.00 | ||
Net Working Capital | $738,078.00 | ||
EPS | -$0.03 | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -1 | ||
PEG | N/A | ||
Price/Free Cash Flow | -41 | ||
Price/Operating Cash Flow | -41 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||